Spots Global Cancer Trial Database for weekly paclitaxel
Every month we try and update this database with for weekly paclitaxel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer | NCT02344095 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | weekly paclitax... weekly cisplati... oncothermia | - | Seoul National University Hospital | |
| Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer | NCT02102438 | Breast Cancer HER-2 Positive ... | Trastuzumab Weekly Paclitax... Carboplatin | 65 Years - | Instituto do Cancer do Estado de São Paulo | |
| Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients | NCT02903004 | Ovarian Neoplas... | Trabectedin Pegylated Lipos... Topotecan Gemcitabine Weekly Paclitax... Carboplatin | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer | NCT02102438 | Breast Cancer HER-2 Positive ... | Trastuzumab Weekly Paclitax... Carboplatin | 65 Years - | Instituto do Cancer do Estado de São Paulo | |
| A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer | NCT02344095 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | weekly paclitax... weekly cisplati... oncothermia | - | Seoul National University Hospital | |
| A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients | NCT00373620 | Endometrial Can... | paclitaxel | 20 Years - 75 Years | Korean Gynecologic Oncology Group | |
| Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling | NCT03412643 | HER2-negative B... | Doxorubicin Cyclophosphamid... Weekly Paclitax... Trastuzumab Pertuzumab Celcuity CELx H... | 18 Years - | NSABP Foundation Inc | |
| Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) | NCT02279576 | Penile Squamous... | Pazopanib Paclitaxel | 18 Years - | Spanish Oncology Genito-Urinary Group | |
| Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer | NCT02102438 | Breast Cancer HER-2 Positive ... | Trastuzumab Weekly Paclitax... Carboplatin | 65 Years - | Instituto do Cancer do Estado de São Paulo | |
| Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer | NCT03367182 | Ovarian Cancer | Weekly paclitax... Topotecan Pegylated lipos... Bevacizumab | 18 Years - | Yonsei University | |
| A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients | NCT00373620 | Endometrial Can... | paclitaxel | 20 Years - 75 Years | Korean Gynecologic Oncology Group | |
| Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling | NCT03412643 | HER2-negative B... | Doxorubicin Cyclophosphamid... Weekly Paclitax... Trastuzumab Pertuzumab Celcuity CELx H... | 18 Years - | NSABP Foundation Inc | |
| Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients | NCT02903004 | Ovarian Neoplas... | Trabectedin Pegylated Lipos... Topotecan Gemcitabine Weekly Paclitax... Carboplatin | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
